title: Therapeutic effects of LS-13 on glioma in vivo and in vitro.
authors.affiliation: Department of Neurosurgery, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
authors.forename: Wei
authors.initials: W
authors.lastname: Wang
authors.forename: Xiang
authors.initials: X
authors.lastname: Xu
authors.forename: Cheng-Yuan
authors.initials: CY
authors.lastname: Ji
authors.forename: Ling-Yun
authors.initials: LY
authors.lastname: Wu
authors.forename: Zhong
authors.initials: Z
authors.lastname: Wang
authors.forename: Gang
authors.initials: G
authors.lastname: Chen
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy*; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005910:Glioma / Q000188:drug therapy*; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D011804:Quinolines / Q000494:pharmacology / Q000627:therapeutic use*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors; D040321:Vascular Endothelial Growth Factor Receptor-3 / Q000037:antagonists & inhibitors; D023041:Xenograft Model Antitumor Assays
chemical_list: D000970:Antineoplastic Agents; C000598185:LS-13 compound; D011804:Quinolines; D040262:Receptors, Vascular Endothelial Growth Factor; D040321:Vascular Endothelial Growth Factor Receptor-3